VERONA PHARMA PLC - AM
39.90
27-November-24 12:07:41
15 minutes delayed
Stocks
+0.06
+0.15%
Today's range
39.21 - 40.00
ISIN
N/A
Source
NASDAQ
-
21 Feb 2023 01:00:00 By Nasdaq GlobeNewswire
-
20 Dec 2022 01:00:00 By Nasdaq GlobeNewswire
-
19 Dec 2022 15:01:00 By Nasdaq GlobeNewswire
-
Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update
09 Nov 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma Announces November 2022 Investor Conference Participation
02 Nov 2022 02:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Report Third Quarter 2022 Financial Results and Provide Corporate Update
26 Oct 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma Secures Debt Financing of up to $150 Million from Oxford Finance
17 Oct 2022 01:00:00 By Nasdaq GlobeNewswire
-
14 Oct 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference
29 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma strengthens commercialization leadership team
24 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
19 Aug 2022 01:46:07 By Nasdaq GlobeNewswire
-
15 Aug 2022 15:05:00 By Nasdaq GlobeNewswire
-
Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering
10 Aug 2022 19:22:20 By Nasdaq GlobeNewswire
-
Verona Pharma plc Announces Proposed Underwritten Public Offering
09 Aug 2022 15:16:44 By Nasdaq GlobeNewswire
-
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
09 Aug 2022 02:01:03 By Nasdaq GlobeNewswire
-
Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD
09 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2022 15:30:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Report Second Quarter 2022 Financial Results and Provide Corporate Update
29 Jul 2022 01:00:00 By Nasdaq GlobeNewswire
-
09 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Host KOL Event on June 16, 2022
06 Jun 2022 01:00:00 By Nasdaq GlobeNewswire